Yasuro Kumeda Selected Research

Yasuro Kumeda Research Topics

Disease

7	Hypoglycemia (Reactive Hypoglycemia) 03/2022 - 11/2015
6	Diabetes Mellitus 03/2022 - 06/2002
4	Type 2 Diabetes Mellitus (MODY) 08/2019 - 10/2008
3	Cardiovascular Diseases (Cardiovascular Disease) 03/2009 - 12/2005
3	Hypothyroidism 02/2007 - 01/2005
3	Atherosclerosis 12/2005 - 11/2003
2	Graves Disease (Basedow Disease) 02/2010 - 09/2007
2	Bone Resorption 05/2008 - 04/2008
2	Body Weight (Weight, Body) 02/2007 - 09/2005
2	Vascular System Injuries 01/2005 - 02/2004
2	Arthritis (Polyarthritis) 12/2003 - 12/2002
1	Weight Gain 03/2022
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2022
1	Cardiac Arrhythmias (Arrythmia) 01/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022
1	Heart Failure 01/2022
1	Secondary Hyperparathyroidism 01/2021
1	Hypoalbuminemia 08/2019
1	Chronic Kidney Failure (Chronic Renal Failure) 11/2015
1	Chronic Thyroiditis 03/2009
1	Hyperglycemia 05/2008
1	Osteoporosis 05/2008
1	Diabetes Complications 05/2008
1	Hyperthyroidism 09/2007
1	Anemia 03/2007
1	Arteriosclerosis 08/2006
1	Coronary Artery Disease (Coronary Atherosclerosis) 12/2005
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2005
1	Inflammation (Inflammations) 11/2003
1	Rheumatoid Arthritis 12/2002
1	Inappropriate ADH Syndrome (SIADH) 12/2002
1	Bone Diseases (Bone Disease) 06/2002

Drug/Important Bio-Agent (IBA)

6	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2015
5	AlbuminsIBA 01/2022 - 09/2005
5	Indicators and Reagents (Reagents)IBA 10/2008 - 11/2003
4	Insulin Glargine (Lantus)FDA Link 01/2022 - 03/2019
4	Insulin (Novolin)FDA Link 01/2022 - 08/2006
3	insulin degludecIBA 01/2022 - 03/2019
3	Thyroxine (Levothyroxine)FDA LinkGeneric 12/2005 - 11/2003
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 08/2006
2	Phosphates (Orthophosphate)IBA 02/2007 - 09/2005
2	Parathyroid Hormone (Parathormone)IBA 09/2005 - 06/2002
1	insulin glulisine FDA Link 01/2022
1	IDegLiraIBA 01/2022
1	Nonesterified Fatty Acids (NEFA)IBA 01/2022
1	etelcalcetide hydrochlorideIBA 01/2021
1	maxacalcitolIBA 01/2021
1	Calcium-Sensing ReceptorsIBA 01/2021
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2021
1	6- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triolIBA 12/2020
1	ipragliflozinIBA 12/2020
1	Serum AlbuminIBA 08/2019
1	Biomarkers (Surrogate Marker)IBA 08/2019
1	InsulinsIBA 03/2019
1	3- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA 11/2015
1	Pharmaceutical PreparationsIBA 02/2010
1	Sorbitol (Yal)FDA Link 05/2008
1	collagen type I trimeric cross-linked peptideIBA 04/2008
1	Collagen Type I (Type I Collagen)IBA 04/2008
1	Tartrate-Resistant Acid PhosphataseIBA 04/2008
1	Alkaline PhosphataseIBA 04/2008
1	OsteocalcinIBA 04/2008
1	LDL CholesterolIBA 09/2007
1	Immunoglobulin E (IgE)IBA 09/2007
1	Methimazole (Thiamazole)FDA LinkGeneric 09/2007
1	Triglycerides (Triacylglycerol)IBA 09/2007
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2007
1	oxidized low density lipoproteinIBA 09/2007
1	3-FT (3 FT)IBA 09/2007
1	Erythropoietin FDA Link 03/2007
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 03/2007
1	C-Reactive ProteinIBA 02/2007
1	Proteins (Proteins, Gene)FDA Link 02/2007
1	ThrombomodulinIBA 12/2005
1	AdiponectinIBA 12/2005
1	AdipokinesIBA 12/2005
1	MagnesiumIBA 11/2005
1	von Willebrand FactorIBA 01/2005
1	Thyroid HormonesIBA 02/2004
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 12/2003
1	CholesterolIBA 11/2003
1	CreatinineIBA 11/2003
1	CalciumIBA 11/2003
1	mizoribineIBA 12/2002
1	Vasopressins (Vasopressin)IBA 12/2002

Therapy/Procedure

6	Therapeutics 03/2022 - 12/2005
4	Renal Dialysis (Hemodialysis) 01/2021 - 03/2007
3	Glycemic Control 03/2022 - 11/2015
2	Injections 03/2022 - 11/2019